COVID-19期间高血压患者远程药物管理初步研究数据表
COVID-19期间高血压患者远程药物管理研究数据表，评估血压控制、依从性和心血管事件。
基本信息
资源简介
COVID-19期间高血压患者远程药物管理初步研究数据表
【一句话概览】
本数据集是 figshare 公开的结构化表格数据集，收录 1 个文件、合计 753.62 KB，主题涵盖 telemedicine medication management、usual care、hypertension management、COVID-19 pandemic、blood pressure，可用于统计建模、特征工程与队列分析，CC BY 4.0 许可开放获取。
【数据集背景】
本数据集源站标题为《Data_Sheet_1_Evaluation of pharmacist-led telemedicine medication management for hypertension established patients during COVID-19 pandemic: A pilot study.docx》。配套论文《Evaluation of Remote Pharmacist-Led Outpatient Service for Geriatric Patients on Rivaroxaban for Nonvalvular Atrial Fibrillation During the COVID-19 Pandemic》发表于 Frontiers in Pharmacology（2020），DOI：10.3389/fphar.2020.01275。源站首次发布：2022-12-16。
【数据内容】
源站原始描述：AimTo evaluate the impact of a telemedicine medication management service in patients with hypertension. MethodsParticipants were allocated to either a telemedicine service (N = 173) or usual care (UC) (N = 179). The primary outcome was blood pressure (BP) reduction from baseline to the 6-month follow-up visit, the proportion of the target BP achievement, overall adherence to prescribed medication as well as a composite of non-fatal stroke, non-fatal myocardial infarction and cardiovascular deat…
中文译文（机器翻译，仅供快速理解，请以原文为准）：目的评估远程医疗药物管理服务对高血压患者的影响。方法将参与者分配至远程医疗服务组（N = 173）或常规护理组（UC）（N = 179）。主要结局为从基线至6个月随访就诊时的血压（BP）降幅、血压达标比例、对处方药物的总体依从性，以及非致死性卒中、非致死性心肌梗死和心血管死亡的复合终点。结果6个月时，干预组89.6%（n = 155）的患者血压得到控制，UC组为78.8%（n = 141）（OR = 1.14，95% CI = 1.04–1.25，P = 0.006），收缩压和舒张压的平均差异分别为−6.0（−13.0至−2.5 mmHg）和−2.0 mmHg（−4.0至−0.1 mmHg）。干预组17.9%（n = 31）的患者用药不依从，UC组为29.1%（n = 52）（P = 0.014）。干预组和对照组分别有2.9%和4.5%达到复合临床终点，差异无统计学意义（OR = 1.566，95% CI = 0.528–4.646）。结论在COVID-19疫情期间，用于高血压管理的远程医疗药物管理较UC带来了更好的血压控制和用药依从性改善，从而减少了总体不良心血管事件的发生。
【数据结构与技术规格】
文件数 1 个，合计 753.62 KB。Data_Sheet_1_Evaluation of pharmacist-led telemedicine medication management for hypertension established patients during COVID-19 pandemic: A pilot s.docx：application/vnd.openxmlformats-officedocument.wordprocessingml.document，753.62 KB。数据集 DOI：10.3389/fpubh.2022.1091484.s001。
【主题与分类】
源站学科分类：Aboriginal and Torres Strait Islander Health、Aged Health Care、Care for Disabled、Community Child Health、Environmental and Occupational Health and Safety、Epidemiology。主题标签：telemedicine medication management、usual care、hypertension management、COVID-19 pandemic、blood pressure。
【适用方向】
结构化表格数据可直接用于统计建模、特征工程与队列分析。
【获取与许可】
源站页面：https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_Evaluation_of_pharmacist-led_telemedicine_medication_management_for_hypertension_established_patients_during_COVID-19_pandemic_A_pilot_study_docx/21738860
使用许可：CC BY 4.0（https://creativecommons.org/licenses/by/4.0/）。
规范引用：Li, Xiaoye; Hu, Jialu; Yao, Yao; Zuo, Chengchun; Wang, Zi; Li, Xiaoyu; et al. (2022). Data_Sheet_1_Evaluation of pharmacist-led telemedicine medication management for hypertension established patients during COVID-19 pandemic: A pilot study.docx. Frontiers. Dataset
【使用注意】
· 源站最后修改于 2023-06-01，引用时请注意版本时效。
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载，适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档，适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务（收技术服务费，非数据销售）
暂未开放当前数据集主要来源为 Kaggle 公开托管，完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取（Figshare）
- 源站标题：Data_Sheet_1_Evaluation of pharmacist-led telemedicine medication management for hypertension established patients during COVID-19 pandemic: A pilot study.docx
- DOI：10.3389/fpubh.2022.1091484.s001
- 发布日期：2022-12-16
- 文件数：1 个
- 文件总体积：753.62 KB
- 源站页面：https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_Evaluation_of_pharmacist-led_telemedicine_medication_management_for_hypertension_established_patients_during_COVID-19_pandemic_A_pilot_study_docx/21738860
命令行下载
curl -L -o "Data_Sheet_1_Evaluation of pharmacist-led telemedicine medication management for hypertension established patients during COVID-19 pandemic: A pilot s.docx" "https://ndownloader.figshare.com/files/38568575"
文件清单
Data_Sheet_1_Evaluation of pharmacist-led telemedicine medication management for hypertension established patients during COVID-19 pandemic: A pilot s.docx（753.62 KB）
文件总体积 753.62 KB（源站 API 实测）。
数据加载示例（图像类）
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
数据说明
AimTo evaluate the impact of a telemedicine medication management service in patients with hypertension.
MethodsParticipants were allocated to either a telemedicine service (N = 173) or usual care (UC) (N = 179). The primary outcome was blood pressure (BP) reduction from baseline to the 6-month follow-up visit, the proportion of the target BP achievement, overall adherence to prescribed medication as well as a composite of non-fatal stroke, non-fatal myocardial infarction and cardiovascular death.
ResultsAt 6 months, BP was controlled in 89.6% (n = 155) of intervention patients and 78.8% (n = 141) of UC patients (OR = 1.14, 95% CI = 1.04–1.25, P = 0.006), giving a mean difference of −6.0 (−13.0 to −2.5 mmHg) and −2.0 mmHg (−4.0 to −0.1 mmHg) in SBP and DBP, respectively. 17.9% (n = 31) of the patients in the intervention group were non-adherent with medications, compared with 29.1% (n = 52) in the UC group (P = 0.014). The composite clinical endpoints were reached by 2.9% in the intervention group and 4.5% in the control group with no significant differences (OR = 1.566, 95% CI = 0.528–4.646).
ConclusionTelemedicine medication management for hypertension management had led to better BP control and medication adherence improvement than UC during COVID-19 epidemic, resulting in a reduction of overall adverse cardiovascular events occurrence.
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.3389/fpubh.2022.1091484.s001（source: https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_Evaluation_of_pharmacist-led_telemedicine_medication_management_for_hypertension_established_patients_during_COVID-19_pandemic_A_pilot_study_docx/21738860）。
数据缺失？
依托陕西、四川两大基地，我们与超过十家三甲医院建立直接合作关系，覆盖合规授权、采集治理、专业标注、数据交付的全流程，为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务？立即联系我们获取专业方案。
